tiprankstipranks
Envoy Medical (COCH)
NASDAQ:COCH
US Market
COCH
Envoy Medical
RESEARCH TOOLSreports
Want to see COCH full AI Analyst Report?

Envoy Medical (COCH) Ratios

120 Followers

Envoy Medical Ratios

COCH's free cash flow for Q4 2025 was $-1.81. For the 2025 fiscal year, COCH's free cash flow was decreased by $ and operating cash flow was $-89.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Mar 25Mar 24Dec 22
Liquidity Ratios
Current Ratio
 0.54 0.54 1.24 1.02 0.65
Quick Ratio
 0.41 0.41 1.02 0.83 0.14
Cash Ratio
 0.32 0.32 0.73 0.58 0.07
Solvency Ratio
 -1.15 -1.15 -0.68 -2.96 -0.41
Operating Cash Flow Ratio
 -1.57 -1.57 -2.38 -2.35 -3.50
Short-Term Operating Cash Flow Coverage
 -104.60 -104.60 0.00 0.00 -19.65
Net Current Asset Value
$ -14.05M$ -14.05M$ -21.00M$ -2.59M$ -37.10M
Leverage Ratios
Debt-to-Assets Ratio
 0.11 0.11 1.70 0.07 13.51
Debt-to-Equity Ratio
 -0.08 -0.08 -1.04 -0.32 -0.95
Debt-to-Capital Ratio
 -0.08 -0.08 24.01 -0.46 -20.80
Long-Term Debt-to-Capital Ratio
 -0.07 -0.07 -148.54 0.00 -11.94
Financial Leverage Ratio
 -0.73 -0.73 -0.61 -4.66 -0.07
Debt Service Coverage Ratio
 -5.49 -12.45 -24.27 0.00 -19.27
Interest Coverage Ratio
 -5.82 -14.01 -23.60 0.00 0.00
Debt to Market Cap
 0.06 0.07 0.70 0.00 0.33
Interest Debt Per Share
 0.24 0.13 1.09 0.04 3.40
Net Debt to EBITDA
 0.13 0.13 -0.72 0.12 -3.98
Profitability Margins
Gross Profit Margin
-262.66%-262.66%-229.78%-149.68%-110.13%
EBIT Margin
-9240.66%-9240.66%-8879.56%-9468.99%-3673.42%
EBITDA Margin
-9115.35%-9115.35%-8802.67%-9426.90%-3641.77%
Operating Profit Margin
-9240.66%-9240.66%-8558.22%-5809.81%-3673.42%
Pretax Profit Margin
-9857.26%-9857.26%-9242.22%-9468.99%-6718.57%
Net Profit Margin
-9857.26%-9857.26%-9242.22%-9468.99%-6718.57%
Continuous Operations Profit Margin
-9857.26%-9857.26%-9242.22%-9468.99%-6718.57%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
106.67%106.67%107.99%162.98%182.90%
Return on Assets (ROA)
-277.59%-277.59%-180.23%-361.77%-622.97%
Return on Equity (ROE)
129.49%201.89%110.37%1684.80%43.99%
Return on Capital Employed (ROCE)
741.34%741.34%-481.40%-1861.97%-23529.73%
Return on Invested Capital (ROIC)
786.93%786.93%-464.78%-1604.81%-1427.21%
Return on Tangible Assets
-277.59%-277.59%-180.23%-361.77%-622.97%
Earnings Yield
-179.08%-183.34%-77.39%-131.65%-15.65%
Efficiency Ratios
Receivables Turnover
 7.09 7.09 0.28 4.51 5.78
Payables Turnover
 0.30 0.30 0.45 0.51 0.50
Inventory Turnover
 0.57 0.57 0.43 0.56 0.38
Fixed Asset Turnover
 0.13 0.13 0.10 0.39 0.26
Asset Turnover
 0.03 0.03 0.02 0.04 0.09
Working Capital Turnover Ratio
 -0.06 -0.14 0.22 -0.90 2.62
Cash Conversion Cycle
 -522.32 -522.32 1.35K 11.46 277.16
Days of Sales Outstanding
 51.49 51.49 1.33K 80.85 63.14
Days of Inventory Outstanding
 645.64 645.64 840.19 649.51 949.15
Days of Payables Outstanding
 1.22K 1.22K 812.64 718.90 735.13
Operating Cycle
 697.13 697.13 2.17K 730.36 1.01K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.93 -0.93 -0.96 -1.36 -0.87
Free Cash Flow Per Share
 -0.94 -0.94 -1.01 -1.37 -0.89
CapEx Per Share
 <0.01 <0.01 0.05 0.01 0.02
Free Cash Flow to Operating Cash Flow
 1.01 1.01 1.05 1.01 1.02
Dividend Paid and CapEx Coverage Ratio
 -9.11 -9.11 -5.24 -111.71 -40.39
Capital Expenditure Coverage Ratio
 -101.68 -101.68 -18.32 -111.71 -40.39
Operating Cash Flow Coverage Ratio
 -19.81 -19.81 -0.91 -30.41 -0.25
Operating Cash Flow to Sales Ratio
 -75.52 -75.52 -79.77 -54.09 -37.15
Free Cash Flow Yield
-130.56%-141.85%-70.45%-75.87%-8.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.56 -0.55 -1.29 -0.76 -6.39
Price-to-Sales (P/S) Ratio
 58.69 53.77 119.42 71.93 429.30
Price-to-Book (P/B) Ratio
 -1.13 -1.10 -1.43 -12.80 -2.81
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.77 -0.70 -1.42 -1.32 -11.28
Price-to-Operating Cash Flow Ratio
 -0.73 -0.71 -1.50 -1.33 -11.56
Price-to-Earnings Growth (PEG) Ratio
 -0.04 0.03 0.03 -0.01 -0.13
Price-to-Fair Value
 -1.13 -1.10 -1.43 -12.80 -2.81
Enterprise Value Multiple
 -0.52 -0.46 -2.07 -0.64 -15.77
Enterprise Value
 11.26M 10.14M 41.05M 19.07M 136.10M
EV to EBITDA
 -0.51 -0.46 -2.07 -0.64 -15.77
EV to Sales
 46.71 42.06 182.43 60.36 574.24
EV to Free Cash Flow
 -0.61 -0.55 -2.17 -1.11 -15.08
EV to Operating Cash Flow
 -0.62 -0.56 -2.29 -1.12 -15.46
Tangible Book Value Per Share
 -0.60 -0.60 -1.00 -0.14 -3.56
Shareholders’ Equity Per Share
 -0.60 -0.60 -1.00 -0.14 -3.56
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.01 0.01 0.01 0.03 0.02
Net Income Per Share
 -1.21 -1.21 -1.11 -2.38 -1.57
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.07 1.07 1.04 1.00 1.83
Research & Development to Revenue
 51.81 51.81 45.24 28.34 20.99
SG&A to Revenue
 37.97 37.97 38.04 22.99 10.91
Stock-Based Compensation to Revenue
 2.35 0.37 0.00 4.98 0.00
Income Quality
 0.77 0.77 0.80 0.57 0.55
Currency in USD